Loading
Latest filing published 20 May 2026 for 派林生物.
司文彬 discloses dealings in 派林生物 to SSE / SZSE (CSRC). Over a trading history stretching from 19 May 2026 to 20 May 2026, the count stands at 2 filings.
The open-market record is one-sided, with 2 purchases worth €14k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The record was last updated on 20 May 2026 with an open-market purchase (€8,092) in 派林生物. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.